East Brunswick, N.J., December 7, 2016 (BUSINESSWIRE) – (Cronus Pharma LLC, an emerging animal health company focused on the development and marketing of prescription pharmaceuticals to improve the lives and health of companion animals, announced the commercial launch of Clindamycin Hydrochloride Oral Liquid (25mg/20mL) in a 20mL bottle, a generic version of Antirobe Aquadrops®. Clindamycin […]
Product Portfolio
Trusted products that help veterinarians deliver better care, everyday
Happy Thanksgiving!
This Thanksgiving, we express our deepest gratitude to our compassionate employees whose dedication drives everything we do. We are thankful for our customers who place their trust in Cronus Pharma, and for our partners who help us strengthen our capabilities to deliver quality and cost-effective medicines. Your support inspires us to continue making a meaningful […]
Cronus Pharma initiating Voluntary Recall for Florfenicol Injection (250 mL, 500 mL), Xylazine Hydrochloride (50 mL), and Ketamine Hydrochloride (10 mL) Due to Precautionary Measure
Cronus Pharma LLC, a fully integrated research, development, manufacturing, sales and marketing animal health pharmaceutical company, announces the launch of Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution for immediate availability in the U.S. animal health market through national and regional distributors.
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution
Cronus Pharma LLC, a fully integrated research, development, manufacturing, sales and marketing animal health pharmaceutical company, announces the launch of Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution for immediate availability in the U.S. animal health market through national and regional distributors.
Cronus Pharma LLC initiating Voluntary Recall for of Dexmedetomidine Hydrochloride Injection 0.5 mg/mL For Veterinary Use Due to Presence of Particulate Matter
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company.
Cronus Pharma Hires Todd Brodersen as Senior Director of Sales & Marketing
Mr. Brodersen has 30 years of animal health sales and marketing leadership experience EAST BRUNSWICK, N.J.–(BUSINESS WIRE)– Cronus Pharma LLC, a fully integrated research & development, manufacturing and marketing animal health pharmaceutical company, announced Mr. Todd Brodersen has joined as Senior Director of Sales & Marketing. Mr. Brodersen has thirty years of animal health industry […]
Animal Pharm Article Cronus: Animal health’s buoyancy is spawning need for more cost-effective generic pharmaceuticals
September 21, 2020 – Cronus Pharma believes US FDA approval for its new manufacturing site will be a major milestone on its way to becoming a veterinary generic pharmaceuticals leader. The East Brunswick, New Jersey-headquartered business started life bringing crossover drugs from the humanpharmaceuticals market into animal health. Now it has become a fully integrated […]
Cronus Pharma Launches Clindamycin Hydrochloride Oral Liquid
East Brunswick, N.J., December 7, 2016 (BUSINESSWIRE) – (Cronus Pharma LLC, an emerging animal health company focused on the development and marketing of prescription pharmaceuticals to improve the lives and health of companion animals, announced the commercial launch of Clindamycin Hydrochloride Oral Liquid (25mg/20mL) in a 20mL bottle, a generic version of Antirobe Aquadrops®. Clindamycin […]